Skip to content

{ Category Archives } Spinal cord injury

Technology and Robotics in Rehabilitation

The growing use of robotic technology in neurorehabilitation promises a brighter future for patients who have residual deficits from their neurological insult. MossRehab is today a center of research and therapeutic use of rehabilitation interventions that make use of robotic devices for patients with stroke and traumatic brain injury. “The rationale for using robots in [...]

MossRehab Conducting Exclusive U.S. Trial of ReWalk

MossRehab is the exclusive site in the U.S. for clinical trials of ReWalk™, the first commercially viable upright device that enables wheelchair users to stand, walk, and climb stairs. In July, two individuals with spinal cord injuries demonstrated the use of ReWalk at MossRehab’s Gain and Motion Analysis Lab, moving independently from a wheelchair to [...]

Open Patient Enrollment for MossRehab Trials

ZolpidemPrincipal Investigator: John Whyte, MD, PhD Trial location: MossRehab   This trial seeks to define more precisely the proportion of patients in the vegetative and minimally conscious states (VS/MCS) who have a clinically meaningful response to zolpidem with improvement in their level of consciousness. It will use cutting-edge research methods (functional neuroimaging, event related potentials, [...]

Answering the Call: MossRehab Helps Outpatients Stay Connected with Lifelong Living Programs

When persons are discharged back to their homes following an acute inpatient rehab stay, celebration can quickly give way to bewilderment. Even after months or years of functional improvement, they may be stunned by the difficulty of common household tasks. Worse still, some may experience a profound sense of isolation, as they discover that participating [...]

MossRehab Awarded Three-Year CARF Accreditations

As part of MossRehab’s ongoing commitment to quality and transparency, we choose to undergo triennial reviews by the Commission for Accreditation of Rehabilitation Facilities (CARF). This year, we are proud to announce that CARF’s comprehensive survey and inspection of all of our operations has resulted in three-year accreditation for a total of 15 MossRehab programs. [...]

MossRehab to Perform Exclusive U.S.Trial of ReWalk(TM)

MossRehab will soon begin the exclusive U.S. clinical trial for a new assistive technology called the ReWalk. The ReWalk is a motorized exoskeleton suit that enables patients with lower limb disabilities, including complete paralysis, to independently engage in ambulatory activities, such as standing, walking and in some cases climbing stairs.The ReWalk consists of a lightweight [...]

Successful reduction of neuropathic pain associated with spinal cord injury via of a combination of intrathecal hydromorphone and ziconotide: a case report.

by Michael Saulino, MD Moss Rehabilitation Research Institute, Albert Einstein Healthcare Network, Philadelphia, PA. STUDY DESIGN: Case report. OBJECTIVES: To report a novel management strategy for neuropathic pain management after spinal cord injury. SETTING: Outpatient spinal cord injury (SCI) clinic. METHODS: The patient demonstrated two neuropathic pain syndromes, namely at- and below-level pain. These syndromes [...]

A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury.

by Leonard Kamen, DO, Herbert R. Henney, Jacob D. Runyan Albert Einstein Medical Center, Moss Rehabilitation Outpatient Center, Philadelphia, PA, USA.  OBJECTIVE: Tizanidine is an imidazoline central alpha(2)-adrenoceptor agonist widely used to manage spasticity secondary to conditions such as multiple sclerosis (MS), stroke, and spinal cord injury (SCI). While there is widespread use of tizanidine [...]

Human exoskeleton suit helps paralyzed people walk

By Ari Rabinovitch HAIFA, Israel (Reuters) – paralyzed for the past 20 years, former Israeli paratrooper Radi Kaiof now walks down the street with a dim mechanical hum. That is the sound of an electronic exoskeleton moving the 41-year-old’s legs and propelling him forward — with a proud expression on his face — as passersby [...]

Three phase bone scintigraphy identifying complex regional pain syndrome as etiology of autonomic dysreflexia associated with positional changes in spinal cord injury.

by Jimmy M. Henry MD, Harry Schwartz MD Click here to view poster

Successful Reduction of Neuropathic Pain Associated With Spinal Cord Injury Via a Combination of Intrathecal Hydromorphone and Ziconotide: A Case Report

by Michael Saulino, MD, PhD Physiatrist, MossRehab; Assistant Professor, Dept. of Rehabilitation Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA Click here to view poster

Pulmonary Management of a Patient With Complete Thoracic Spinal Cord Injury and Coexisting Internal Injuries

by Amy C. Van Dyke, PT; Janet Parker, MSPT; Robin Myers, PT, NCS MossRehab Neurologic Physical Therapy Residency Program, Philadelphia, PA Click here to view poster